Alzheimer's Disease

Politics

[Japan’s First] New Alzheimer’s Disease Drug “Lecanemab” Approved, Eliminates Causative Substance, First in Japan

On August 21, an expert panel of the Ministry of Health, Labor, and Welfare (MHLW) approved the manufacturing and market...

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny